Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...

Advances delivered what may feel like medical miracles, including the first bladder transplant, a lifesaving personalized ...

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

For patients with relapsed or refractory multiple myeloma, treatment with teclistamab plus daratumumab is associated with a significant PFS benefit.

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

Researchers identify stem cell–based molecular subtypes that improve prognosis prediction in colorectal cancer and support ...

Some cancer patients at The University of Texas MD Anderson Cancer Center got an unexpected boost. After receiving the ...

Researchers have discovered how cells activate a last-resort DNA repair system when severe damage strikes. When genetic ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

From GLP-1 weight-loss drugs and mRNA cancer vaccines to longevity science and regenerative medicine, 2025 marked a decisive ...